SEC Form 5 · accession 0001267602-18-000039
ALIMERA SCIENCES INC · ALIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C. Daniel Myers
Officer — CEO · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 8, 2018 · 6:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 15, 2017 | G | 500 | $0.00 | D | 198,661 | D | |
| Common Stock | Feb 15, 2017 | G | 500 | $0.00 | D | 198,161 | D | |
| Common Stock | Feb 15, 2017 | G | 500 | $0.00 | D | 197,661 | D | |
| Common Stock | Apr 28, 2017 | A | 2,453 | $1.0625 | A | 200,114 | D | |
| Common Stock | Oct 31, 2017 | A | 2,494 | $1.0455 | A | 202,608 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).